Log In
Print this Print this

NextSeq CN500

  Manage Alerts
Collapse Summary General Information
Company Illumina Inc.
DescriptionHigh throughput, next-generation sequencing test using Berry's Bambni assay and Illumina's NextSeq 500 Sequencing System
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentApproved
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect fetal trisomies 13, 18 and 21
Regulatory Designation
PartnerBerry Genomics Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today